Many Growth Opportunities Emerging in the U.S. Infectious Disease In-Vitro Diagnostics Market.
This research service, titled U.S. Infectious Disease Diagnostics Markets, provides comprehensive analysis of market drivers, restraints, challenges, and trends. Moreover, analysis of market share, competitive structure, revenue forecasts, and products is included. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: molecular infectious disease diagnostics, immunoassay infectious disease diagnostics, and culture infectious disease diagnostics.
Expert analysts thoroughly examine the following market sectors in this research:
The following technologies are covered in this research:
-- Automated antimicrobial susceptibility testing
-- Molecular technologies and assays
-- Microbiology culture methods
The U.S. infectious disease diagnostics market will play a significant role in the dynamic IVD market. This market is segmented according to molecular, immunoassays, and culture infectious disease products. Total market revenues for base year 2005 are $3,823.1 with a CAGR of 7.7%. The most substantial growth is expected in the molecular segment. The U.S. infectious disease diagnostics market is highly competitive and saturated.
Tremendous growth opportunities exist in the U.S. infectious disease in-vitro diagnostics market. High growth areas include viral load testing, nosocomial infection screening, rapid influenza detection, and STD testing.
Rapid detection and fast turn-around time (TAT) are able to lower total overall healthcare costs. Quick TAT is especially relevant to infectious disease testing, as fast diagnosis increases treatment options and patient prognosis.
Technical superiority of molecular methods is phasing out other types or more traditional methods, such as culture based tests, which have TATs of only days and are labor intensive.
For more information visit http://www.researchandmarkets.com/reports/c50504
|Printer friendly Cite/link Email Feedback|
|Date:||Feb 16, 2007|
|Previous Article:||New Superior Clinical Trial Results Drive Revenues in the U.S. Anticoagulant Market.|
|Next Article:||Allen Iverson/LeBron James All-Star Weekend Celebration to Conclude with the LeBron James Celebrity All-Star Weekend Grand Finale.|